Does REGADENOSON Cause Product packaging quantity issue? 14 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Product packaging quantity issue have been filed in association with REGADENOSON (Regadenoson). This represents 0.5% of all adverse event reports for REGADENOSON.
14
Reports of Product packaging quantity issue with REGADENOSON
0.5%
of all REGADENOSON reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From REGADENOSON?
Of the 14 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGADENOSON. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does REGADENOSON Cause?
Nausea (311)
Dyspnoea (271)
Seizure (247)
Vomiting (233)
Injection site extravasation (226)
Hypotension (200)
Headache (190)
Cardiac arrest (183)
Dizziness (160)
Blood pressure decreased (143)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which REGADENOSON Alternatives Have Lower Product packaging quantity issue Risk?
REGADENOSON vs REGORAFENIB
REGADENOSON vs REGORAFENIB\REGORAFENIB
REGADENOSON vs RELATLIMAB
REGADENOSON vs RELPAX
REGADENOSON vs RELUGOLIX